We Believe in Partnering

Overview

Together We Can Reach Any Patient Anywhere

Our objective is to ensure that NexoBrid is accessible to burn patients around the world. We are making substantial progress by collaborating and engaging with leaders in various geographic regions, thereby extending our global presence. By working together, we aim to establish NexoBrid as the new benchmark in burn patient care, enhancing their well-being and quality of life.

We are actively expanding the commercialization of NexoBrid through global partnerships. Currently, we operate in over 44 countries and are determined to accelerate our momentum. We firmly believe that success lies in people. Exceptional individuals make exceptional partners. By combining our technology and team with our partners’ professionalism, local marketing expertise, and sales knowledge, we will significantly elevate the standard of care for patients.

Strategic Partnerships

To advance our mission, we actively pursue collaborations and seek strategic partnerships. By joining forces with like-minded organizations and individuals, we can amplify our impact and drive meaningful change. Together, we can work towards our shared goals and make a lasting difference in the communities we serve. If you are interested in partnering with us or would like to explore collaboration opportunities, we welcome your involvement and encourage you to reach out. Together, we can create a brighter future.

We are proud of our strategic collaboration in the U.S with the Advanced Biomedical, Research and Development Authority (BARDA), supporting the development and authorization of NexoBrid in the U.S, as well as procurement of NexoBrid for the U.S national emergency stockpile. We are also delighted to be in partnership with the U.S. Department of Defense to develop NexoBrid as a non-surgical solution for treating burns in field conditions.

In addition, in the private sector, we signed a collaboration agreement with Vericel (Nasdaq: VCEL) for North America. Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets to market and sell NexoBrid to the 140 burn centers across the U.S.

$216M

contracts value

$50M

additional procurement

$125M

Sales milestones

140

Burn Centers

Global Outreach

We strongly believe in empowering our distributors. We recognize the value they bring to our mission and the critical role they play in delivering NexoBrid to burn patients worldwide.

We employ a comprehensive approach to the global commercialization of NexoBrid, utilizing multiple sales channels. Our strategy involves leveraging various avenues to reach our target markets effectively. This includes utilizing our dedicated European direct sales force, as well as engaging sales representatives and partnering with local distributors across the European Union and Asia. By leveraging these diverse sales channels, we ensure widespread availability and accessibility of NexoBrid to burn patients in these regions.

44

COUNTRIES

MediWound Germany GmbH

Romania

Tel: +972 77 971 4100

MediWound Germany GmbH

Poland

Tel:

MediWound Germany GmbH

Italy

Tel: +972 77 971 4100244

MediWound Germany GmbH

United Kingdom

Tel: +972 77 971 4100

MediWound Germany GmbH

Spain

Tel: +972 77 971 4100

MediWound Germany GmbH

Norway

Tel: +972 77 971 4100

MediWound Germany GmbH

Germany, Austria, Switzerland

Tel: +972 77 971 4100

MediWound Germany GmbH

Belgium

Tel: +972 77 971 4100

MediWound Ltd.

Israel

Tel: +972 77 971 4100

Leander Healthcare B.V.

Netherlands, Luxemburg

Tel: +31 30 755 5380

Innova Medical Oy

Finland

Tel: +385 (0)50 4347412

Expomédica – Sociedade Exportadora E Importadora Material Médico, Lda

Portugal

Tel: +351 217957285

Avalon Pharmaceuticals S.A.

Panama

Tel: +57 1 6160255

Vericel Corporation

Mexico

Tel: +1 (617) 588-5555

Verciel Corporation

Canada

Tel: +1 (617) 588-5555

Vericel Corporation

U.S.A

Tel: +1 (617) 588-5555

Specialty Therapeutics PC

Bulgaria

Tel: + 30 213 02 33 913

Specialty Therapeutics PC

Greece, Cyprus, Malta

Tel: + 30 213 02 33 913

Genfa Medica S.A.

France

Tel: +41 22 710 05 50

Genfa Medica S.A.

Russia

Tel: + 41 22 710 05 50

Kaken Pharmaceutical Co., Ltd.

Japan

Tel: +81-3-5977-5046 Fax: +81-3-5977-5133

Learning Organization, LLC

Bangladesh

Tel: murali@learning-organized.com

Leraning Organization , LLC

Sri Lanka

Tel: murali@learning-organized.com

Balance Medical Pty. Ltd.

Australia

Tel: +61 1300 668 099

Learning Organized LLC

India

Tel: murali@learning-organized.com

BL&H Co., Ltd.

South Korea

Tel: +82-2-3282-4710 FAX: +82-2-3281-9081

Holy Stone Healthcare Co., Ltd.

The Republic of China (Taiwan)

Tel: +886-2-8797-5966 Fax: +886-2-2627-9729

Genfa Medica S.A.

Ukraine

Tel: +41 22 710 05 50

Ghassan Aboud Group FZE

United Arab Emirates

Tel: +971 4 881 6244

Asia Orphan ILAC SAN. TIC. A.S.

Turkey

Tel: +90 312 285 10 15

Genfa Medica S.A.

Latvia, Lithuania, Estonia

Tel: +41 22 710 05 50

Balance Medical Pty. Ltd.

New Zealand

Tel: + 61 1300 668 099

Avalon Pharmaceuticals S.A.

Colombia

Tel: +57 1 6160255

Avalon Pharmaceuticals S.A.

Chile

Tel: +57 1 6160255

Avalon Pharmaceuticals S.A.

Peru

Tel: +57 1 6160255

TUTEUR S.A.C.I.F.I.A.

Argentina

Tel: +54 11 5787 2222

Avalon Pharmaceuticals S.A.

Ecuador

Tel: +57 1 6160255

  • Direct distribution
  • Sales representative
  • Distributors

Distributors

Our Partners

Join Us

Become a Distributor

We are deeply committed to bringing innovative and life-changing therapies to patients worldwide. Our dedication to improving healthcare outcomes drives us to continuously seek new collaborations and partnerships. By joining forces with like-minded organizations and individuals, we can leverage collective expertise, resources, and networks to accelerate the development, accessibility, and adoption of groundbreaking therapies. We are excited about the future opportunities for collaboration and the positive impact we can make together in transforming patients' lives globally.